Cost-Effectiveness of Screening for Primary Aldosteronism and Subtype Diagnosis in the Resistant Hypertensive Patients

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Circulation. Cardiovascular Quality and Outcomes

• Publication date

  2015-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1161/CIRCOUTCOMES.115.002002PMID 26555126PMCID PMC4651757
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cost-Effectiveness in Health and Medicine

  2016cited by this paper
• Cost-effectiveness in health and medicine

  2016cited by this paper
• Cost-effectiveness of 10-Year Risk Thresholds for Initiation of Statin Therapy for Primary Prevention of Cardiovascular Disease.

  2015influential reference
• Apparent and true resistant hypertension: definition, prevalence and outcomes

  2014cited by this paper
• Prognosis of primary aldosteronism in Japan: results from a nationwide epidemiological study.

  2014cited by this paper
• Test characteristics of the aldosterone-to-renin ratio as a screening test for primary aldosteronism

  2014cited by this paper
• Executive summary: heart disease and stroke statistics--2014 update: a report from the American Heart Association.

  2014cited by this paper
• Updating cost-effectiveness--the curious resilience of the $50,000-per-QALY threshold.

  2014cited by this paper
• An Expert Consensus Statement on Use of Adrenal Vein Sampling for the Subtyping of Primary Aldosteronism

  2014cited by this paper
• ACC/AHA statement on cost/value methodology in clinical practice guidelines and performance measures: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures and Task Force on Practice Guidelines.

  2014cited by this paper
• ACC/AHA statement on cost/value methodology in clinical practice guidelines and performance measures: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures and Task Force on Practice Guidelines.

  2014cited by this paper
• Meta-analysis of trials comparing laparoscopic transperitoneal and retroperitoneal adrenalectomy.

  2013cited by this paper
• Addition of spironolactone in patients with resistant arterial hypertension (ASPIRANT-EXT): a randomized, double-blind, placebo-controlled trial

  2013cited by this paper
• Long-Term Control of Arterial Hypertension and Regression of Left Ventricular Hypertrophy With Treatment of Primary Aldosteronism

  2013cited by this paper
• Hyperaldosteronism as a common cause of resistant hypertension.

  2013cited by this paper
• More americans living longer with cardiovascular disease will increase costs while lowering quality of life.

  2013cited by this paper
• Prevalence of and risk factors for primary aldosteronism among patients with resistant hypertension in China

  2013cited by this paper
• Heart disease and stroke statistics--2012 update: a report from the American Heart Association.

  2012cited by this paper
• Abstracts From the 33rd Annual Scientific Meeting of the High Blood Pressure Research Council of Australia

  2012cited by this paper
• Quality of life in patients with primary aldosteronism: gender differences in untreated and long-term treated patients and associations with treatment and aldosterone.

  2012cited by this paper
• Confirmatory testing in primary aldosteronism.

  2012cited by this paper
• The Adrenal Vein Sampling International Study (AVIS) for identifying the major subtypes of primary aldosteronism.

  2012cited by this paper
• What is the prevalence of resistant hypertension in the United States?

  2012cited by this paper
• Long-Term Survival and Recurrence After Acute Myocardial Infarction in England, 2004 to 2010

  2012cited by this paper
• Uncontrolled and Apparent Treatment Resistant Hypertension in the United States, 1988 to 2008

  2012cited by this paper
• Practice Advisory for Preanesthesia Evaluation: An Updated Report by the American Society of Anesthesiologists Task Force on Preanesthesia Evaluation

  2012cited by this paper
• Blood pressure and medication changes following adrenalectomy for unilateral primary aldosteronism: a follow-up study

  2012cited by this paper
• Addition of spironolactone in patients with resistant arterial hypertension (ASPIRANT)--study protocol.

  2011cited by this paper
• Prevalence of Resistant Hypertension in the United States, 2003–2008

  2011cited by this paper
• Medical and surgical evaluation and treatment of adrenal incidentalomas.

  2011cited by this paper
• Psychological assessment of primary aldosteronism: a controlled study.

  2011cited by this paper
• Uncontrolled and Apparent Treatment Resistant Hypertension in the United States, 1988 to 2008

  2011cited by this paper
• Adrenal Venous Sampling: Evaluation of the German Conn's Registry

  2011cited by this paper
• Resistant Hypertension and Undiagnosed Primary Hyperaldosteronism Detected by Use of a Computerized Database

  2011cited by this paper
• Addition of Spironolactone in Patients With Resistant Arterial Hypertension (ASPIRANT): A Randomized, Double-Blind, Placebo-Controlled Trial

  2011cited by this paper
• Quality of life in patients with bilateral primary aldosteronism before and during treatment with spironolactone and/or amiloride, including a comparison with our previously published results in those with unilateral disease treated surgically.

  2011cited by this paper
• Outcome of Surgery for Primary Hyperaldosteronism

  2011cited by this paper
• Adrenal vein sampling for Primary Aldosteronism: time for a reality check

  2010cited by this paper
• Management of resistant arterial hypertension: role of spironolactone versus double blockade of the renin–angiotensin–aldosterone system

  2010cited by this paper
• Rapid Reversal of Left Ventricular Hypertrophy and Intracardiac Volume Overload in Patients With Resistant Hypertension and Hyperaldosteronism: A Prospective Clinical Study

  2010cited by this paper
• Prevalence and Antimicrobial Susceptibility Profile of ESBL- and KPC-producing Enterobacteriaceae in the United States (2003 − 2008)

  2010cited by this paper
• Stewart PM and Allolio B. Adrenal vein sampling for primary aldosteronism: time for a reality check Response

  2010cited by this paper
• Cost-Effectiveness of Using High-Sensitivity C-Reactive Protein to Identify Intermediate- and Low-Cardiovascular-Risk Individuals for Statin Therapy

  2010cited by this paper
• The management of aldosterone-producing adrenal adenomas--does adrenalectomy increase costs?

  2010cited by this paper
• Acute myocardial infarction hospitalization in the United States, 1979 to 2005.

  2010cited by this paper
• American Association of Clinical Endocrinologists and American Association of Endocrine Surgeons Medical Guidelines for the Management of Adrenal Incidentalomas: executive summary of recommendations.

  2009cited by this paper
• American Association of Clinical Endocrinologists medical guidelines for clinical practice for growth hormone use in growth hormone-deficient adults and transition patients - 2009 update.

  2009cited by this paper
• The American Association of Clinical Endocrinologists and American Association of Endocrine Surgeons medical guidelines for the management of adrenal incidentalomas.

  2009cited by this paper
• On the prevalence of adrenocortical adenomas in an autopsy material in relation to hypertension and diabetes.

  2009cited by this paper
• Intrarenal hemodynamics in primary aldosteronism before and after treatment.

  2009cited by this paper
• Systematic Review: Diagnostic Procedures to Differentiate Unilateral From Bilateral Adrenal Abnormality in Primary Aldosteronism

  2009cited by this paper
• Adrenal vein sampling for primary aldosteronism: the assessment of selectivity and lateralization of aldosterone excess baseline and after adrenocorticotropic hormone (ACTH) stimulation

  2008cited by this paper
• Incidental adrenal lesions: principles, techniques, and algorithms for imaging characterization.

  2008cited by this paper
• The incidental adrenal mass on CT: prevalence of adrenal disease in 1,049 consecutive adrenal masses in patients with no known malignancy.

  2008cited by this paper
• Resistant hypertension: diagnosis, evaluation, and treatment. A scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research.

  2008cited by this paper
• Sudden cardiac death in patients with stable coronary artery disease and preserved left ventricular systolic function.

  2008cited by this paper
• Plasma and urine aldosterone to plasma renin activity ratio in the diagnosis of primary aldosteronism

  2008cited by this paper
• Keeping the noise down: common random numbers for disease simulation modeling

  2008cited by this paper
• Cardiovascular outcomes in patients with primary aldosteronism after treatment.

  2008cited by this paper
• Case detection, diagnosis, and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline.

  2008cited by this paper
• Regional variation in out-of-hospital cardiac arrest incidence and outcome.

  2008cited by this paper
• Prevalence of primary hyperaldosteronism in resistant hypertension: a retrospective observational study.

  2008cited by this paper
• What Does the Value of Modern Medicine Say About the $50,000 per Quality-Adjusted Life-Year Decision Rule?

  2008cited by this paper
• Blood pressure outcome of adrenalectomy in patients with primary hyperaldosteronism with or without unilateral adenoma

  2008cited by this paper
• Diagnostic accuracy of adrenal venous sampling in comparison with other parameters in primary aldosteronism.

  2008cited by this paper
• Resistant hypertension: diagnosis, evaluation, and treatment: a scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research.

  2008cited by this paper
• Deaths: leading causes for 2004.

  2007cited by this paper
• The incidentally discovered adrenal mass

  2007cited by this paper
• Effect of Spironolactone on Blood Pressure in Subjects With Resistant Hypertension

  2007cited by this paper
• Clinical practice. The incidentally discovered adrenal mass.

  2007cited by this paper
• Long-Term Cardiac Effects of Adrenalectomy or Mineralocorticoid Antagonists in Patients With Primary Aldosteronism

  2007cited by this paper
• Explaining the decrease in U.S. deaths from coronary disease, 1980-2000.

  2007cited by this paper
• OUTCOMES OF LAPAROSCOPIC ADRENALECTOMY FOR HYPERLADOSTERONISM

  2007cited by this paper
• Confirmatory testing in normokalaemic primary aldosteronism: the value of the saline infusion test and urinary aldosterone metabolites.

  2006cited by this paper
• A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients.

  2006cited by this paper
• Prevalence of adrenal incidentaloma in a contemporary computerized tomography series

  2006cited by this paper
• Short-term and long-term outcomes in 133 429 emergency patients admitted with angina or myocardial infarction in Scotland, 1990–2000: population-based cohort study

  2006cited by this paper
• Comparison of confirmatory tests for the diagnosis of primary aldosteronism.

  2006cited by this paper
• Primary hyperaldosteronism: effect of adrenal vein sampling on surgical outcome.

  2006cited by this paper
• Preference-Based EQ-5D Index Scores for Chronic Conditions in the United States

  2006cited by this paper
• Screening for primary aldosteronism in essential hypertension: diagnostic accuracy of the ratio of plasma aldosterone concentration to plasma renin activity.

  2005cited by this paper
• Risk of Myocardial Infarction and Vascular Death After Transient Ischemic Attack and Ischemic Stroke: A Systematic Review and Meta-Analysis

  2005cited by this paper
• The role of aldosterone antagonists in the management of resistant hypertension

  2005cited by this paper
• Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism.

  2005cited by this paper
• Validity of plasma aldosterone-to-renin activity ratio in African American and white subjects with resistant hypertension.

  2005cited by this paper
• Cost-Effectiveness Analysis of Hypertension Guidelines in South Africa: Absolute Risk Versus Blood Pressure Level

  2005cited by this paper
• The clinically inapparent adrenal mass: update in diagnosis and management.

  2004cited by this paper
• Role for adrenal venous sampling in primary aldosteronism.

  2004cited by this paper
• Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents.

  2004cited by this paper
• Sudden death and recurrent ischemic events after myocardial infarction in the community.

  2004cited by this paper
• Procedural volume as a marker of quality for CABG surgery.

  2004cited by this paper
• Ten-Year Risk of First Recurrent Stroke and Disability After First-Ever Stroke in the Perth Community Stroke Study

  2004cited by this paper
• Prognosis of angina with and without a diagnosis: 11 year follow up in the Whitehall II prospective cohort study

  2003cited by this paper
• Prevalence and natural history of adrenal incidentalomas.

  2003cited by this paper
• Primary aldosteronism - treatment options.

  2003cited by this paper
• Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials.

  2003cited by this paper
• Prevalence of primary hyperaldosteronism in moderate to severe hypertension in the Central Europe region

  2003cited by this paper
• The underlying risk of death after myocardial infarction in the absence of treatment.

  2002cited by this paper
• Hyperaldosteronism Among Black and White Subjects With Resistant Hypertension

  2002cited by this paper
• Identification of the etiology of primary aldosteronism with adrenal vein sampling in patients with equivocal computed tomography and magnetic resonance findings: results in 104 consecutive cases.

  2001cited by this paper

• Clinical manifestations of primary aldosteronism and cardiometabolic risk.

  2026cites this paper
• Broadening Primary Aldosteronism Screening: Alignment Across Contemporary Guidelines.

  2026cites this paper
• Re: Pierre Letourneau, Lara Cabezas, Aurélie De Mul, et al. Optimizing Screening Performance for the Risk of Hyperoxaluria and Urolithiasis Using the Urinary Oxalate/Creatinine Ratio: A Retrospective Analysis. Eur Urol Open Sci 2025;75:20–8

  2025cites this paper
• The significance of high expression of circulating miR-222-3p in patients with unilateral primary aldosteronism.

  2025cites this paper
• Primary Aldosteronism: An Endocrine Society Clinical Practice Guideline.

  2025cites this paper
• Shifting paradigms in primary aldosteronism: reconsideration of screening strategy via integrating pathophysiological insights

  2025cites this paper
• The saline infusion test with mass spectrometric measurements of aldosterone to confirm primary aldosteronism

  2025cites this paper
• Screening and Diagnosis Trends for Primary Aldosteronism: A Longitudinal Nationwide Cohort Study of 7.8 Million People

  2025cites this paper
• Cost-Effectiveness of Routine Monitoring of Long-Term Conditions in Primary Care: Informing Decision Modelling with a Systematic Review in Hypertension, Type 2 Diabetes and Chronic Kidney Disease

  2024cites this paper
• Cost-effectiveness analysis of segmental adrenal venous sampling with radiofrequency ablation for primary aldosteronism in Japan

  2024cites this paper
• Value of interventional radiology and their contributions to modern medical systems

  2024cites this paper
• Screening and diagnosis of primary aldosteronism. Consensus document of all the Spanish Societies involved in the management of primary aldosteronism

  2024cites this paper
• Optimizing the aldosterone-to-renin ratio cut-off for screening primary aldosteronism based on cardiovascular risk: a collaborative study

  2024cites this paper
• Cost-effectiveness of screening for primary aldosteronism in hypertensive patients in Australia: a Markov modelling analysis

  2023influential citation
• Nghiên cứu tỷ nồng độ Aldosterone/Renin huyết thanh ở bệnh nhân tăng huyết áp

  2023cites this paper
• Underdiagnosis of Primary Aldosteronism: A Review of Screening and Detection.

  2023cites this paper
• Japan Endocrine Society clinical practice guideline for the diagnosis and management of primary aldosteronism 2021.

  2022cites this paper
• Clinical Translationality of KCNJ5 Mutation in Aldosterone Producing Adenoma

  2022cites this paper
• Primary Aldosteronism Screening Rates Differ with Sex, Race, and Comorbidities

  2022cites this paper
• Ambulatory fludrocortisone suppression test in the diagnosis of primary aldosteronism: Safety, accuracy and cost‐effectiveness

  2022cites this paper
• Effect of Hypokalemia on Screening for Primary Aldosteronism

  2022cites this paper
• Cost-effectiveness of adrenal vein sampling- vs computed tomography-guided adrenalectomy for unilateral adrenaloma in primary aldosteronism

  2022cites this paper
• Primary Aldosteronism and Ischemic Heart Disease

  2022cites this paper
• Screening for primary aldosteronism is underutilised in patients with chronic kidney disease

  2022cites this paper
• Should Adrenal Venous Sampling Be Performed in PA Patients Without Apparent Adrenal Tumors?

  2021cites this paper
• Drug-resistant hypertension in primary aldosteronism patients undergoing adrenal vein sampling: the AVIS-2-RH study.

  2021cites this paper
• Cost‐effectiveness analysis of screening for primary aldosteronism in China

  2021cites this paper
• Screening for primary aldosteronism in the hypertensive obstructive sleep apnea population is cost-saving.

  2021cites this paper
• Diagnosis and treatment of primary aldosteronism.

  2021cites this paper
• Testing for Primary Aldosteronism and Mineralocorticoid Receptor Antagonist Use Among U.S. Veterans

  2020influential citation
• Adrenal venous sampling guided adrenalectomy rates in primary aldosteronism: results of an international cohort (AVSTAT).

  2020cites this paper
• Development of a prediction score to avoid confirmatory testing in patients with suspected primary aldosteronism.

  2020cites this paper
• Primary aldosteronism is a public health issue: challenges and opportunities

  2020cites this paper
• Not All Hypertension Is a Lifelong Disease: A Teachable Moment.

  2020cites this paper
• Primary aldosteronism in a general population sample. The Czech post-MONICA study

  2020cites this paper
• Screening Rates for Primary Aldosteronism in Resistant Hypertension

  2020cites this paper
• Primary aldosteronism.

  2020cites this paper
• Association of Outcome Definitions With Success Following Adrenalectomy for Primary Aldosteronism.

  2019cites this paper
• Primary Aldosteronism and Obstructive Sleep Apnea: A Cross-Sectional Multi-Ethnic Study.

  2019cites this paper
• Steroid Profiling and Immunohistochemistry for Subtyping and Outcome Prediction in Primary Aldosteronism—a Review

  2019cites this paper
• Primary aldosteronism with nonlocalizing imaging

  2019cites this paper
• A Novel High-Resolution Magnetic Resonance Imaging Protocol Detects Aldosterone-Producing Adenomas in Patients With Negative Computed Tomography

  2018cites this paper
• Call for screening for primary aldosteronism: an underdiagnosed and treatable disease.

  2018cites this paper
• Primary Aldosteronism.

  2018cites this paper
• Is it time to screen all patients with hypertension for primary aldosteronism?

  2018cites this paper
• Primary Aldosteronism and Cardiovascular Events: It Is Time to Take Guideline Recommendations Seriously.

  2018cites this paper
• Anxiety, Depression, and Impaired Quality of Life in Primary Aldosteronism: Why We Shouldn't Ignore It!

  2018cites this paper
• Primary Aldosteronism and Its Various Scenarios

  2018cites this paper
• Prevalence of primary aldosteronism in primary care: a cross-sectional study.

  2018cites this paper
• Validation of a Cardiovascular Disease Policy Microsimulation Model Using Both Survival and Receiver Operating Characteristic Curves

  2017cites this paper
• Quantitative Value of Aldosterone‐Renin Ratio for Detection of Aldosterone‐Producing Adenoma: The Aldosterone‐Renin Ratio for Primary Aldosteronism (AQUARR) Study

  2017cites this paper
• An App for the Diagnosis of Primary Aldosteronism.

  2016cites this paper
• A useful tool to improve the case detection rate of primary aldosteronism: the aldosterone-renin ratio (ARR)-App.

  2016cites this paper
• The Aldosterone Renin Ratio (ARR) APP as Tool to Enhance the Detection Rate of Primary Aldosteronism

  2016cites this paper